跳至主要内容
临床试验/CTRI/2024/10/074775
CTRI/2024/10/074775已完成Unknown

A Clinical Study to Evaluation Of Tan Reduction Potential of Ozone D-Tan Facial Cleanser on Healthy Human Volunteers

Ozone Pharmaceuticals Ltd1 个研究点 分布在 1 个国家目标入组 32 人开始时间: 2024年10月11日最近更新:

试验速览

阶段
Unknown
状态
已完成
发起方
入组人数
32
试验地点
1
主要终点
1.Skin Lightness- by Spectrophotometer

研究概览

简要总结

A Clinical study to Evaluate the Anti Tan Activity of D Tain Facial Cleanser, where Anti Tan activity of the product will be assessed following measurements will be done

1.  Skin pigmentation by Mexameter

2. Skin lightening/detan by Chromameter/spectrophotometer

Assessment will be done at T0, T15 min

Instant D Tan was observed on 32 Healthy Human Volunteers

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 45.00 Year(s)(—)

入选标准

  • Gender: Male or Female with age 18-45 2)Subjects with mild pigmentation and tan.
  • Subjects willing to give written informed consent 4)Women of child bearing potential must have a negative urine pregnancy test prior to study entry.
  • Are free of any systemic or dermatologic disorder, which, in the opinion of the investigator, will interfere with the study results or increase the risk of adverse events.
  • Are willing to avoid prolonged exposure of the treatment area to ultraviolet radiation (natural or artificial) for the duration of the study.

排除标准

  • 1.Subjects who are pregnant, breast-feeding, or planning to become pregnant during the study.
  • 2.Have any evidence of systemic cancer, squamous cell carcinoma, basal cell carcinoma, in the last 5 years, or any other confounding skin condition.
  • 3.Have open sores or open lesions in the treatment area(s).
  • 4.Have any condition that, in the opinion of the investigator, would confound the safety and/or efficacy assessments of the product.
  • 5.Have participated in any interventional clinical trial in the previous 90 days.
  • 6.Have a known sensitivity to any of the constituents of the test product including sensitivities 7.Have used, are using, or are planning to use.

结局指标

主要结局

1.Skin Lightness- by Spectrophotometer

时间窗: At T0, T15min

2. Instant Skin Detain

时间窗: At T0, T15min

3. Instant melanin Reduction

时间窗: At T0, T15min

次要结局

  • Not Applicable(Not Applicable)

研究者

发起方
Ozone Pharmaceuticals Ltd
申办方类型
Pharmaceutical industry-Indian
责任方
Principal Investigator
主要研究者

Dr Robin Chugh

CCFT Laboratories

研究点 (1)

Loading locations...

相似试验